TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH CON-COMITANT CARDIOVASCULAR DISEASE

Download full text PDF
Issue: 
7
Year: 
2016

Professor N. Grigoryeva (1), MD; M. Kapustina (1); Professor A. Kuznetsov (1), MD; T. Koroleva (2) 1 -Nizhny Novgorod State Medical Academy 2 -City Clinical Hospital Five, Nizhny Novgorod

The paper gives the results of indacaterol treatment in 20 patients with chronic obstructive pulmonary disease and concomitant coronary heart disease.

Keywords: 
pulmonology
cardiology
coronary heart disease
chronic obstructive pulmonary disease
premature beats
heart rate



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Barnes P. Chronic obstructive pulmonary disease // N. Engl. J. Med. – 2000; 1. 343 (4): 269–80.
  2. Global Initiative for Chronic Obstructive Lung Diseases (GOLD). Global strategy 2. for diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO workshop report. Updated 2009. www.goldcopd.org
  3. Casanova C. et al. Inspiratory-to-Total Lung Capacity Ratio Predicts Mortality 3. in Patients with Chronic Obstructive Pulmonary Disease // Am. J. Resp. Crit. Care Med. – 2005; 171: 591–7.
  4. Avdeev S.N., Bajmakanova G.E. Strategija vedenija kardiologicheskogo 4. patsienta, stradajuschego HOBL. Kardiopul'monologicheskie vzaimootnoshenija // Serdtse. – 2007; 6 (6): 305–9.
  5. Sin D., Man S. Why are patients with chronic obstructive pulmonary disease at 5. increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease // Circulation. – 2003; 107: 1514–9.
  6. Krasnova Ju.N., Petuhova E.A., Dzizinskij A.A. Bezopasnost' tiotropi-6. um bromida u bol'nyh HOBL s soputstvujuschej ishemicheskoj bolezn'ju serdtsa // Pul'monologija. – 2006; 1: 94–6.
  7. Bova A.A. Sovremennye podhody k diagnostike i lecheniju IBS u bol'-7. nyh HOBL // Med. novosti. – 2007; 9: 7–14.
  8. Sviridov A.A., Mantsurova A.V., Grineva Z.O. Bezbolevaja ishemija mio-8. karda u bol'nyh hronicheskimi obstruktivnymi zabolevanijami legkih i vozmozhnosti lechenija // Ros. kardiol. zhurn. – 2000; 1: 68–72.
  9. Javelov I.S. O bezopasnosti dlitel'no dejstvujuschih 9. β2-agonistov. Vzgljad kardiologa // Pul'monologija. – 2007; 1: 112–6.
  10. Tsvetkova O.A., Belov A.A., Bujanova O.E. Effektivnost' i bezopasnost' 10. terapii atroventom i berodualom u bol'nyh hronicheskoj obstruktivnoj bolezn'ju legkih v sochetanii s ishemicheskoj bolezn'ju serdtsa // Pul'monologija. – 2002; 3: 100–6.
  11. Avdeev S.N. Onbrez Brizhaler: aktual'nye voprosy // Consilium 11. Medicum. – 2012; 14 (3): 79–86.
  12. Fox K., Garcia M., Ardissino D. et al. Guidelines on the management of 12. stable angina pectoris: executive summary: the Task Force on the Management of Stable angina pectoris of the European Society of Cardiology // Eur. Heart J. – 2006; 27 (11): 1341–81.
  13. Diagnostika i lechenie stabil'noj stenokardii: Rossijskie rekomen-13. datsii (2-j peresm.) / Vserossijskoe nauchnoe obschestvo kardiologov. Kardiovask. ter. i profilak. – 2008 (pril. 4): 7 (6).
  14. Grigor'eva N.Ju., Kuznetsov A.N., Nekrasov A.A. i dr. Sravnitel'naja 14. otsenka klinicheskoj effektivnosti i bezopasnosti β-adrenoblokatora bisoprolola i antagonista kal'tsija verapamila u bol'nyh stabil'noj steno-kardiej v sochetanii s hronicheskoj obstruktivnoj bolezn'ju legkih (rezul'-taty dvuhletnego nabljudenija) // Sistemnye gipertenzii. – 2011; 1: 22–5.